$53.75
0.02 (+0.04%)
Gilead Sciences, Inc. (NASDAQ:GILD)
CAPS Rating:
A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.
A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.